Alex Thurman

“Well, first, I'll say as much as I'd love you and want to give you all the details, we're in the middle of our budget season right now. But that being said, you can think about three things that, and you've kind of already covered them as we think about 2027 and incremental spend and operating expenses.”

“Ryan, first of all, you know, I love you. Thank you so much for recognizing me. That's great. Thanks for the question. As it pertains to gross margins, you're right.”

“Chris and I are grateful for you taking the time and the effort to do what we do over the Zoom today. As you know, or for those in the room that we apologize, we actually made a good faith effort to get there yesterday.”

“SLT well it's interesting because it's certainly something that wasn't on our radar previously and when we sell an IDOS we sell it to the customer we don't know what patient is going into or doesn't but what we can do is we've looked at some data that one of the high volume surgeons did dr. said to Morian and in that…”

“I'm going to have Chris read this for us. Just kidding. Let's move on. So we'll start out with kind of just a company overview. For those of you who don't know us, Glaucus has been around for about 20, a little over 20 years.”